4.7 Article

4-Octyl itaconate treatment inhibits mitochondrial dysfunction and ER stress via stimulating SIRT1 expression in vitro and attenuates osteoarthritis process in murine DMM model in vivo

Journal

JOURNAL OF FUNCTIONAL FOODS
Volume 102, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.jff.2023.105450

Keywords

Reactive oxygen species; Osteoarthritis; Endoplasmic reticulum; Mitochondrial dysfunction; 4-Octyl itaconate

Ask authors/readers for more resources

This study found that 4-octyl itaconate (4-OI) can impede the progression of osteoarthritis (OA) by promoting the expression of SIRT1 gene, thus inhibiting apoptosis, extracellular matrix degeneration, mitochondrial dysfunction, endoplasmic reticulum stress, and excessive accumulation of reactive oxygen species.
Osteoarthritis (OA), a degenerative disease, has many pathological factors, including oxidative stress (OS), endoplasmic reticulum (ER) stress, apoptosis, and extracellular matrix (ECM) degeneration. OS regulates the pathological progression of OA via mitochondrial dysfunction, and ER stress and by modulating the derivation and elimination of reactive oxygen species (ROS). Though. 4-octyl itaconate (4-OI) is known for its effects on the treatment of various diseases, how it affects OA and its underlying mechanism still needs to be elucidated. Therefore, it is necessary to explore the effects of 4-OI both in vivo and in vitro. In our study, we used H2O2, which can accumulate ROS, OS and ER stress, to imitate the OA model in vitro. Using western blot, real-time quanti-tative reverse transcription polymerase chain reaction and immunofluorescence staining, we found that 125 mu M 4-OI can inhibit apoptosis, ECM degeneration, mitochondrial dysfunction, ER stress and abundant accumulation of ROS in chondrocytes. We also showed that 4-OI can activate the Sirtuin1 gene (SIRT1). We used a SIRT1 inhibitor EX527 to identify the relationships among these pathological factors, and it showed that the 4-OI-medi-ated effect was achieved by promoting the SIRT1. In vivo, the bilateral medial meniscus was resected to establish the destabilization of the medial meniscus model wherein intraperitoneal injections of 2% and 5% 4-OI post-poned the progression of OA. Collectively, this study confirmed that 4-OI can potentially impede the progression of OA by promoting the expression of SIRT1.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available